Although APOE4 is associated with a dose-dependent risk for AD with a 15-fold increased risk in APOE4 homozygotes [26], a lack of relationship between APOE4 and AGD onset has also been reported [36, 38]. Here, APOE is linked to argyrophilic grain disease.